Breadcrumb

Banner - Translational Research in Respiratory Diseases Program -RESP

RESP  |  Translational Research in Respiratory Diseases Program

RESP News heading

News

Asset Publisher

Nip it in the bud: New study will attack SARS-Cov2 where it multiplies

RI-MUHC researchers initiate a clinical trial of ciclesonide to possibly prevent mild cases of COVID-19 from worsening

RI-MUHC researcher Maziar Divangahi honoured by the Royal Society of Canada

Recognition for high-level achievement in research into pulmonary infectious diseases

Systematic testing of groups at increased risk of SARS-CoV-2: an affordable and reasonable approach

In a new cost-analysis study, researchers recommend widespread testing of priority groups, including healthcare workers, school students and staff...

Old drug, new therapy: RI-MUHC-sponsored phase III clinical trial ready to test repurposed dapsone to tone down lung inflammation caused by COVID-19

Reformulated and patented version of well-known generic drug could prove to be a quick, safe and cost-effective way to accelerate recovery and prevent hospitalizations

Research suggests greater access to specific HIV and tuberculosis medications is needed worldwide

Postdoctoral fellows at the RI-MUHC carried out primary statistical analyses for study published in The Lancet

Canada Research Chairs Program announces new and renewed chairs

Congratulations to five RI-MUHC researchers!

Recipient of the 2020-2021 Dr. Margaret Becklake Fellowship: Mikashmi Kohli

A postdoctoral fellow from the RI-MUHC is recognized for international work on TB diagnostics

Three COVID-19 projects at the RI-MUHC to receive CIHR funding

A $109M fund aims to mitigate impact of the pandemic on care delivery in Canada and beyond, as well as contribute to better understanding of the disease

Rifampin for Latent TB: Shorter and safer than the standard treatment, but also cheaper

A new study shows that rifampin regimen is cheaper than isoniazid for latent tuberculosis

Why do some non-smokers get COPD while many heavy smokers don’t?

A new study highlights a strong risk factor for COPD related to lung development

Results of MI4 Emergency COVID-19 Research Funding (Round 2)

RI-MUHC researchers awarded MUHC Foundation funding for a second round of projects with potential impact in a short timeframe

We Care About Rare!

Researchers, advocates and patients gather on Rare Disease Research Day at the RI-MUHC

Results of MI4 Emergency COVID-19 Research Funding (Round 1)

RI-MUHC researchers awarded MUHC Foundation funding for projects with potential impact in a short timeframe

FRQ to create a province-wide COVID-19 Biobank

RI-MUHC researchers take leading roles in the initiative

The Pfizer Investigator Training Program comes to the RI-MUHC!

Clinical research educational training program benefits researchers, staff and students at the inaugural event

Rare respiratory diseases: Combining immunology and respiratory expertise for children and adults

The RI-MUHC is one of eight research centres participating in an NIH-funded project to accelerate the understanding of rare suppurative respiratory diseases...

Pulling out all the stops at the RI-MUHC’s first Open House for prospective trainees

World-renowned researchers. Vibrant learning environment. First-class facilities. If it sounds too good to be true, you weren’t at the Open House!

Dr. Jean Bourbeau named distinguished CHEST Educator

“The greatest achievement is seen in the people we train,” says director of the McConnell Centre for Innovative Medicine

Research shines bright at the MUHC

Congratulations to RI-MUHC researchers who received Foundation awards, scholarships and grants!

See Archive - RESP